Showing results (111-120 of 676) with videos related to
Sort By:
Pageof 68
Clinical Advances in Hematology & Oncology : H&O|February 6, 2009
Utility of brain FDG-PET in primary CNS lymphomaNimish A Mohile, Lisa M Deangelis, Lauren E AbreyClinical Advances in Hematology & Oncology : H&O|May 8, 2010
Recent advances in the treatment of T-cell lymphomasClinical Advances in Hematology & Oncology : H&O|March 31, 2010
Hypomethylating agent induction therapy followed by hematopoietic cell transplantation is feasible in patients with myelodysplastic syndromesChristopher R Cogle, Iman Imanirad, Laura E Wiggins, et al.Clinical Advances in Hematology & Oncology : H&O|July 4, 2007
Diagnosis and management of autoimmune complications of chronic lymphocytic leukemia/ small lymphocytic lymphomaWei Ding, Clive S ZentClinical Advances in Hematology & Oncology : H&O|September 25, 2010
Phase II trial of FOLFOX6, bevacizumab, and cetuximab in the first-line treatment of metastatic colorectal cancerDavid R Spigel, F Anthony Greco, David Waterhouse, et al.Clinical Advances in Hematology & Oncology : H&O|December 29, 2012
Clinical roundtable monograph: Paroxysmal nocturnal hemoglobinuria: a case-based discussionJeff Szer, Anita Hill, Ilene Ceil WeitzClinical Advances in Hematology & Oncology : H&O|December 29, 2012
Personalized care in uterine cancerDavid A Iglesias, Diane C BodurkaClinical Advances in Hematology & Oncology : H&O|December 29, 2012
The tumor microenvironment in follicular lymphomaZhi-Zhang Yang, Stephen M AnsellClinical Advances in Hematology & Oncology : H&O|July 25, 2013
Efficacy of bisphosphonates and other bone-targeted agents in metastatic bone disease from solid tumors other than breast and prostate cancersSyed Mustafa Karim, Janet Brown, Jamal ZekriClinical Advances in Hematology & Oncology : H&O|November 29, 2012
Atypical hemolytic uremic syndrome (aHUS): making the diagnosisJeffrey LaurencePageof 68